BRPI0000967B1 - processos para preparaÇço de compostos secretagogos de hormânio de crescimento. - Google Patents

processos para preparaÇço de compostos secretagogos de hormânio de crescimento.

Info

Publication number
BRPI0000967B1
BRPI0000967B1 BRPI0000967-9A BRPI0000967A BRPI0000967B1 BR PI0000967 B1 BRPI0000967 B1 BR PI0000967B1 BR PI0000967 A BRPI0000967 A BR PI0000967A BR PI0000967 B1 BRPI0000967 B1 BR PI0000967B1
Authority
BR
Brazil
Prior art keywords
processes
growth hormone
hormone secretagogue
secretagogue compounds
preparing growth
Prior art date
Application number
BRPI0000967-9A
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to BRPI0017522A priority Critical patent/BRPI0017522B8/pt
Publication of BRPI0000967A publication Critical patent/BRPI0000967A/pt
Publication of BRPI0000967B1 publication Critical patent/BRPI0000967B1/pt
Publication of BRPI0000967B8 publication Critical patent/BRPI0000967B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0000967A 1999-02-26 2000-02-28 processos para preparação de compostos secretagogos de hormônio de crescimento BRPI0000967B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (3)

Publication Number Publication Date
BRPI0000967A BRPI0000967A (pt) 2001-09-11
BRPI0000967B1 true BRPI0000967B1 (pt) 2012-06-12
BRPI0000967B8 BRPI0000967B8 (pt) 2021-12-07

Family

ID=22404505

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0000967A BRPI0000967B8 (pt) 1999-02-26 2000-02-28 processos para preparação de compostos secretagogos de hormônio de crescimento
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Country Status (43)

Country Link
US (2) US6541634B2 (pt)
EP (2) EP1449842A1 (pt)
JP (3) JP3437813B2 (pt)
KR (2) KR100372063B1 (pt)
CN (3) CN1137891C (pt)
AP (1) AP1221A (pt)
AR (2) AR029617A1 (pt)
AT (1) ATE277944T1 (pt)
AU (1) AU764122B2 (pt)
BG (1) BG104175A (pt)
BR (2) BRPI0000967B8 (pt)
CA (1) CA2299495C (pt)
CO (1) CO5160252A1 (pt)
DE (1) DE60014212T2 (pt)
DK (1) DK1031575T3 (pt)
DZ (1) DZ3018A1 (pt)
EA (1) EA003218B1 (pt)
EE (1) EE200000193A (pt)
ES (1) ES2226712T3 (pt)
GT (1) GT200000018A (pt)
HN (1) HN2000000021A (pt)
HR (1) HRP20000103A2 (pt)
HU (1) HUP0000907A3 (pt)
ID (1) ID24861A (pt)
IL (2) IL134599A (pt)
IN (1) IN192352B (pt)
IS (1) IS5380A (pt)
MA (1) MA25072A1 (pt)
NO (1) NO20000965L (pt)
NZ (1) NZ503062A (pt)
OA (1) OA11325A (pt)
PA (1) PA8491201A1 (pt)
PE (1) PE20001550A1 (pt)
PL (1) PL338628A1 (pt)
PT (1) PT1031575E (pt)
SG (1) SG90096A1 (pt)
SI (1) SI1031575T1 (pt)
SK (1) SK284982B6 (pt)
TN (1) TNSN00035A1 (pt)
TR (1) TR200000536A2 (pt)
TW (2) TW200718702A (pt)
UA (1) UA70306C2 (pt)
ZA (1) ZA200000888B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
WO2014192294A1 (en) * 2013-05-28 2014-12-04 Raqualia Pharma Inc. Polymorph forms
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法
CN120265641A (zh) * 2023-04-21 2025-07-04 长春金赛药业有限责任公司 GHSR 1a激动剂、药物组合物及其制备方法和应用
CN119285632A (zh) * 2024-10-09 2025-01-10 威海中腾医药科技有限公司 一种基于酵母醇脱氢酶催化氧化的卡普瑞林中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
PL322706A1 (en) 1993-11-09 1998-02-16 Merck & Co Inc Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
US6251902B1 (en) 1997-06-25 2001-06-26 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
BG104175A (bg) 2000-12-29
TWI286142B (en) 2007-09-01
EP1031575A1 (en) 2000-08-30
JP2003261565A (ja) 2003-09-19
BRPI0017522B8 (pt) 2021-05-25
CO5160252A1 (es) 2002-05-30
DE60014212T2 (de) 2005-12-15
HRP20000103A2 (en) 2001-04-30
IL134599A0 (en) 2001-04-30
CA2299495C (en) 2010-06-15
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
AP2000001754A0 (en) 2000-03-31
EP1449842A1 (en) 2004-08-25
JP2000247974A (ja) 2000-09-12
US6541634B2 (en) 2003-04-01
AR029617A1 (es) 2003-07-10
PE20001550A1 (es) 2001-01-11
JP2003327585A (ja) 2003-11-19
HN2000000021A (es) 2001-02-02
KR100361783B1 (ko) 2002-11-22
US20030158414A1 (en) 2003-08-21
HU0000907D0 (en) 2000-04-28
BRPI0017522A2 (pt) 2009-12-22
US20020002283A1 (en) 2002-01-03
ID24861A (id) 2000-08-31
EA200000172A3 (ru) 2000-10-30
SG90096A1 (en) 2002-07-23
AP1221A (en) 2003-11-03
AU1947100A (en) 2000-08-31
BRPI0000967A (pt) 2001-09-11
PA8491201A1 (es) 2001-04-30
HK1030219A1 (en) 2001-04-27
SK2302000A3 (en) 2000-11-07
HUP0000907A2 (en) 2001-03-28
DK1031575T3 (da) 2005-01-03
PL338628A1 (en) 2000-08-28
NO20000965L (no) 2000-08-28
IN192352B (pt) 2004-04-10
MA25072A1 (fr) 2000-10-01
PT1031575E (pt) 2004-11-30
IL134599A (en) 2006-12-10
CN1515570A (zh) 2004-07-28
AU764122B2 (en) 2003-08-07
ZA200000888B (en) 2001-08-23
EA200000172A2 (ru) 2000-08-28
NO20000965D0 (no) 2000-02-25
US6673929B2 (en) 2004-01-06
KR100372063B1 (ko) 2003-02-14
DE60014212D1 (de) 2004-11-04
BRPI0017522B1 (pt) 2013-09-24
CA2299495A1 (en) 2000-08-26
KR20010006698A (ko) 2001-01-26
OA11325A (en) 2003-10-27
ES2226712T3 (es) 2005-04-01
UA70306C2 (en) 2004-10-15
ATE277944T1 (de) 2004-10-15
CN1137891C (zh) 2004-02-11
IS5380A (is) 2000-08-27
HUP0000907A3 (en) 2001-05-28
JP4051314B2 (ja) 2008-02-20
IL157103A0 (en) 2004-02-08
CN1837205A (zh) 2006-09-27
CN1270960A (zh) 2000-10-25
EA003218B1 (ru) 2003-02-27
IL157103A (en) 2007-07-24
DZ3018A1 (fr) 2004-03-20
SI1031575T1 (en) 2005-02-28
NZ503062A (en) 2001-07-27
TNSN00035A1 (fr) 2005-11-10
AR053722A2 (es) 2007-05-16
TW200718702A (en) 2007-05-16
SK284982B6 (sk) 2006-03-02
JP3437813B2 (ja) 2003-08-18
KR20020065455A (ko) 2002-08-13
TR200000536A2 (tr) 2000-09-21
BRPI0000967B8 (pt) 2021-12-07
GT200000018A (es) 2001-08-16

Similar Documents

Publication Publication Date Title
ZA200202461B (en) Compounds for the treatment of ischemia.
GB9912724D0 (en) Radio positioning system
ZA200202536B (en) Pharmaceutical tramadol salts.
LV12752A (lv) Heterocyclic aromatic compounds useful as growth hormone secretagogues
ZA200005521B (en) Method for transferring easily-polymerizable substance.
NO20025893L (no) Veksthormon sekretagoga
IT1317741B1 (it) Metodo per la preparazione di 5-cianoftalide.
BR0011702B1 (pt) processo para preparação de derivados herbicidas.
EE200100503A (et) Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks
ZA200108968B (en) New compounds.
ZA200110413B (en) Crystalline 1-methylcarbapenem compounds.
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
BR0014461B1 (pt) composto derivado de 4-hidróxibifenil hidrazida e método para preparar o mesmo.
BRPI0000967B1 (pt) processos para preparaÇço de compostos secretagogos de hormânio de crescimento.
GB9907001D0 (en) Gps for workstations
HUP0201303A3 (en) Novel organic anion transport proteins
HUP0200448A3 (en) Processes for preparing pesticidal intermediates
GB9911180D0 (en) Processes for preparing pesticidal intermediates
IT1307463B1 (it) Antenna multifunzione per autoveicoli
MXPA01013317A (es) Maquina para cristalizacion.
GB9908361D0 (en) High transverse dipole moment aryl compounds
ZA200000578B (en) Process for the preparation of organic azides.
ZA200005361B (en) Positioning arrangement.
ES1043641Y (es) Flexometro perfeccionado.

Legal Events

Date Code Title Description
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/06/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/00, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2162 DE 12/06/2012 QUANTO AO PRAZO DE VALIDADE DE 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/2000, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28.02.2020